QCG
BCAB

Quadrant Capital Group’s BIOATLA INC BCAB Stock Holding History

Quadrant Capital Group’s Portfolio BCAB Stock Details BCAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-20
Closed -$29K – 2509
2021
Q3 		$29K Hold
20
– – ﹤0.01% 1078
2021
Q2 		$42K Hold
20
– – 0.01% 904
2021
Q1 		$51K Sell
20
-4
-17% -$10.3K 0.01% 800
2020
Q4 		$41K Buy
+24
New +$40.1K 0.01% 811

Other funds holding BCAB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Quadrant Capital Group's BCAB Position: Q4 2021 in Review

Quadrant Capital Group sold out of BIOATLA INC (BCAB) in Q4 2021, closing a stake of 20 shares — an estimated $29K sold.

Quadrant Capital Group first reported a position in BCAB in Q4 2020 and held it in 4 quarters. The position peaked at $51K in Q1 2021. 79 funds tracked by Wall St. Rank hold BCAB as of Q4 2021.

  • Quadrant Capital Group reported no remaining BIOATLA INC position as of Q4 2021 after selling out during the quarter.
  • Quadrant Capital Group sold 20 BIOATLA INC shares in Q4 2021, an estimated $29K.
  • Quadrant Capital Group first reported a position in BIOATLA INC in Q4 2020 and held it in 4 quarters.
  • Quadrant Capital Group's BIOATLA INC position peaked at $51K in Q1 2021.
  • 79 funds tracked by Wall St. Rank held BIOATLA INC as of Q4 2021.

Based on Quadrant Capital Group's 13F filing for Q4 2021, filed 1 Feb 2022.